Consider TLR5 for new therapeutic development against COVID‐19

C. Chakraborty, Ashish Ranjan Sharma, M. Bhattacharya, Garima Sharma, Sang-Soo Lee, G. Agoramoorthy

Journal of medical virology, 2020

TLR5, a member of Toll-like receptors (TLRs), has a significant role to recognize the flagellin or same kind of molecule. After reorganization, it can modulate innate immune responses. In this article, we urge for the development of new therapeutic molecule by targeting TLR5 modulation against SARS-CoV-2. This article is protected by copyright. All rights reserved.

Cited by 19 publications.

Field of study: Medicine

10.1002/jmv.25997